6 completed. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Pasteurellaceae Infections: new trials by email Literature Review of Pasteurellaceae Infections trials Research Report on Pasteurellaceae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Reactogenicity Trial of Vaccine for the Prevention of Infections Caused by Haemophilus Influenzae Type b Vaccine for the prevention of infections caused by Haemophilus influenza type b, Placebo - Haemophilus Influenzae Infection, Vaccines | Phase 1 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 60 | 2020-01-14 | 2022-06-02 |
| A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults DTP-HepB-IPV-Hib vaccine, DTP-HepB-Hib vaccine & IPV - Diphtheria, Tetanus | Phase 1 | Completed | LG Chem | 42 | 2017-07-03 | 2019-08-29 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers Pneumococcal vaccine GSK2830930A, Synflorix™ - Infections, Streptococcal | Phase 1 | Completed | GlaxoSmithKline | 61 | 2011-12-12 | 2021-02-10 |
| Nontypeable H. Influenzae in Healthy Adults NTHi Strain 2019 - Haemophilus Influenzae (NTHI) | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2009-08-01 | 2013-04-11 |
| Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults GSK2231395A, Engerix-B - Streptococcus Pneumoniae, Haemophilus Influenzae | Phase 1 | Completed | GlaxoSmithKline | 40 | 2009-01-08 | 2018-08-08 |
| Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b Haemophilus influenzae type b - Haemophilus Influenzae Type b | Phase 1 | Completed | Novartis Vaccines | 40 | 2008-07-01 | 2012-02-08 |
Haemophilus Infections (6) · Diphtheria (1) · Hepatitis B (1) · Poliomyelitis (1) · Streptococcal Infections (1) · Tetanus (1) · Whooping Cough (1)
Bacterial Infections (6) · Bacterial Infections and Mycoses (6) · Gram-Negative Bacterial Infections (6) · Infections (6) · Gram-Positive Bacterial Infections (2) · Actinomycetales Infections (1) · Blood-Borne Infections (1) · Bordetella Infections (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Clostridium Infections (1) · Communicable Diseases (1) · Corynebacterium Infections (1) · DNA Virus Infections (1)
Engerix-B (1) · PHiD-CV vaccine (1) · Poliovirus Vaccine, Inactivated (1) · Vaccines (1)
GlaxoSmithKline (2) · LG Chem (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Novartis Vaccines (1) · St. Petersburg Research Institute of Vaccines and Sera (1)
China (1) · Germany (1) · Russia (1) · South Korea (1) · Sweden (1) · United States (1)
Ellina Ruzanova, PhD (1) · WJ Kim (1)